House Authorizes Obamacare Lawsuit
The House passed a resolution Wednesday authorizing a lawsuit challenging President Barack Obama's constitutional authority to delay the employer mandate in the federal healthcare reform law. The measure was adopted on a 225-201 largely party-line vote.
Immunooncology Collaborations on the Rise
While Incyte and Genentech announced partnership to study each of their immunooncology molecules in NSCLC, AstraZeneca and Kyowa Hakko Kirin signed a similar agreement to evaluate their candidate molecules in multiple solid tumors.
The Gluttony of Cancer Cells
The authors observed that an artificial switch in cancer cells from an epithelial to a mesenchymal phenotype induced the expression of GLUT3, a protein that promotes cellular glucose uptake.
$1,000 Sovaldi Now Hepatitis Treatment of Choice
Even with insurers reluctant to pay, Sovaldi prescriptions have eclipsed those for all other hepatitis C pills combined in a matter of months, new data from IMS Health indicate. The promise of a real cure, with fewer nasty side effects, has prompted thousands to get treated.
First, Do No Harm: AJMC Commentary Calls for New Framework for Comparative Effectiveness Research
Not every patient responds the same way to the same treatment, yet healthcare is moving toward a system based on population health. How can researchers, health plans, and providers respond? This month in The American Journal of Managed Care, Jennifer S. Graff, PharmD, and co-authors call for an approach that identifies when differences in patient responses are mostly like to matter, and offering greater flexibility when the patient’s health is most at stake.
Tentative Deal Reached on VA Reform
The chairmen of the House and Senate Veterans Affairs committees have reached a tentative agreement on a plan to improve veterans' healthcare.
US Paves Way for Novartis to Copy Amgen Biotech Drug
U.S. regulators have accepted an application by Sandoz - the generics arm of Novartis - seeking approval for a copycat version of Amgen's drug Neupogen, or filgrastim, for patients with low white blood cell counts.
Without Medicaid,Hospitals May Pay Patient Premiums
Uncompensated care was supposed to be a thing of the past, but it's persisting in many states not expanding Medicaid eligibility. As an alternative, for some high-cost uninsured patients, hospitals are turning to a new option.